Login

Recent searches

No recent searches

Search options

Only available when logged in.
lepoulsdumonde.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Small french Mastodon instance for friends, family and useful bots

Administered by:

Server stats:

52
active users

lepoulsdumonde.com: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.4.0-alpha.4

Public
HuffPost [ES]

🌐 ■ El daño colateral de los aranceles de Trump pueden revivir uno de los miedos de la pandemia ■ El plan arancelario del presidente de EEUU tiene previsto disparar los impuestos que tiene que pagar las importaciones de  abeto desde Canadá, una materia clave en la producción de papel higiénico.
huffingtonpost.es/global/el-da

#global#eeuu#donaldtrump
Public
Augie Ray

#COVID19 Reinfections are more like to lead to #LongCOVID in kids:

STUDY: Compared to the first infection, a second infection was associated with higher risk of:

- 2.08x overall PASC diagnosis
- 3.60x myocarditis
- 2.28x thrombophlebitis and thromboembolism
- 1.96x heart disease
- 1.89x acute kidney injury
- 1.59x arrhythmias
- 1.56x abnormal liver enzyme
-1.50x fatigue and malaise
-1.35x postural orthostatic tachycardia syndromes
- 1.32x cognitive functions

medrxiv.org/content/10.1101/20

medRxiv · Reinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort StudyIMPORTANCE Post-acute sequelae of SARS-CoV-2 infection (PASC) remains a major public health challenge. While previous studies have focused on characterizing PASC and identifying its subphenotypes in children and adolescents following an initial SARS-CoV-2 infection, the risks of PASC with Omicron-variant reinfections remain unclear. Using a real-world data approach, this study investigates the risks of PASC following reinfections during the Omicron phase in the pediatric population. OBJECTIVE To investigate the risks of PASC diagnosis and 24 PASC symptoms and conditions after reinfection of SARS-CoV-2 during Omicron period in the pediatric population. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used data from the RECOVER consortium comprising 40 children's hospitals and health institutions in U.S. between January 2022 and October 2023. EXPOSURES A second SARS-CoV-2 infection, confirmed by a positive polymerase-chain-reaction (PCR) or antigen tests, or a diagnose of COVID-19, occurring at least 60 days after the initial infection, compared to the initial infection. MAIN OUTCOMES AND MEASURES PASC was identified using two approaches: (1) the ICD-10-CM diagnosis code U09.9 and (2) a symptom-based definition including 24 physician-identified symptoms and conditions. Absolute risks of incident PASC were reported, and relative risks (RRs) were calculated by comparing the second infection episode with the first infection episode groups using a modified Poisson regression model, adjusting for demographic, clinical, and healthcare utilization factors through exact matching and propensity scoring matching. RESULTS A total of 465,717 individuals under 21 years old (mean [SD] age 8.17 [6.58] years; 52% male) were included. Compared to the first infection, a second infection was associated with significantly increased risk of an overall PASC diagnosis (RR, 2.08; 95% confidence interval [CI], 1.68-2.59), and with many specific conditions including: myocarditis (RR, 3.60; 95% CI, 1.46-8.86); changes in taste and smell (RR, 2.83; 95% CI, 1.41-5.67); thrombophlebitis and thromboembolism (RR, 2.28; 95% CI, 1.71-3.04); heart disease (RR, 1.96; 95% CI, 1.69 to 2.28); acute kidney injury (RR, 1.90; 95% CI, 1.38 to 2.61); fluid and electrolyte (RR, 1.89; 95% CI, 1.62 to 2.20); generalized pain (RR, 1.70; 95% CI, 1.48 to 1.95); arrhythmias (RR, 1.59; 95% CI, 1.45-1.74); abnormal liver enzyme (RR, 1.56; 95% CI, 1.24 to 1.96); fatigue and malaise (RR, 1.50; 95% CI, 1.38 to 1.64); musculoskeletal pain (RR, 1.45; 95% CI, 1.37 to 1.54); abdominal pain (RR, 1.42; 95% CI, 1.34 to 1.50); postural orthostatic tachycardia syndromes (POTS)/dysautonomia (RR, 1.35; 95% CI, 1.20 to 1.51); cognitive functions (RR, 1.32; 95% CI, 1.15 to 1.50); and respiratory signs and symptoms (RR, 1.29; 95% CI, 1.25 to 1.33). The risks were consistent across various organ systems, including cardiovascular, respiratory, gastrointestinal, neurological, and musculoskeletal systems. CONCLUSIONS AND RELEVANCE Children and adolescents face significantly higher risk of various PASC outcomes after reinfection with SARS-CoV-2. These findings suggest a cumulative risk of PASC and highlight the urgent need for targeted prevention strategies to reduce reinfections, which includes an increased emphasis on initial or re-vaccination of children. ### Competing Interest Statement Dr. Jhaveri is a consultant for AstraZeneca, Seqirus, Gilead, Sanofi; receives an editorial stipend from the Pediatric Infectious Diseases Society; research support from GSK; and royalties from Up To Date/Wolters Kluwer. All other co-authors have no conflicts of interest to report. ### Funding Statement This research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethnics committee/IRB of University of Pennsylvania waived ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request.
Public
Augie Ray

COVID is NOT just the flu.

STUDY: #COVID19 patients showed 2.02x higher 12-month risks of advanced CKD (chronic kidney disease) and 3.04x higher risks of AKI (Acute Kidney Injury) compared to influenza patients.

nature.com/articles/s41598-025

NatureAssociation between COVID-19 and the development of chronic kidney disease in patients without initial acute kidney injury - Scientific ReportsWhile the association between COVID-19 and acute kidney injury (AKI) is well documented, the impact of COVID-19 on the development of advanced chronic kidney disease (CKD) remains unclear, particularly in patients without initial AKI. Using the TriNetX healthcare database, we conducted a matched cohort study comparing 141,587 COVID-19 and 141,587 influenza patients. We excluded patients with AKI within one month of infection and matched groups on demographics, comorbidities, and baseline laboratory values. The primary outcome was the incidence of advanced CKD (stages 3–5) at the 12-month follow-up. COVID-19 patients showed higher 12-month risks of advanced CKD (hazard ratio [HR]:2.02, 95% confidence interval [CI]:1.69–2.42, p < 0.0001), AKI (HR 3.04, 95%CI:2.61–3.55, p < 0.0001), and estimated glomerular filtration rate < 60 mL/min/1.73 m2 (HR:3.01, 95%CI:2.74–3.30, p < 0.0001) compared to influenza patients. Subgroup analyses showed consistently elevated risks across sexes and in patients over 45 years, while younger patients did not demonstrate an increased risk of advanced CKD at the 12-month follow-up. Diabetes mellitus and hypertension have emerged as the strongest predictors of advanced CKD development. In conclusion, COVID-19 is associated with an increased risk of long-term renal dysfunction compared with influenza, suggesting the need for extended monitoring of kidney function in high-risk populations.
Public *
Hannu Ikonen, MD

Fuck Tim Walz.

Hes a Collaborator too far as im concerned.

"Democratic Governor Tim Walz does Trumpian Return To Office.

We all know that RTO is fossil fueled and caters to commercial real estate to get butts in seats downtown for The Economy. This is NOT a progressive move and Walz should be shamed harshly by Democrat voters in Minnesota for acting like a right-winger on telework.

'Gov. Walz announce change to state telework policy By WDIO Minnesota Governor Tim Walz announced an update to the state’s telework policy for state workers. The change would require most state agency employees to work in-person for at least 50% of their scheduled work days. This would go in effect on June 1, 2025. “This approach balances the flexibility of telework with the workplace advantages of being in office,” said Gov. Walz. “Having more state employees in the office means that collaboration can happen more quickly and state agencies can build strong organizational cultures more easily.” '

That collaboration nonsense is all bullshit and we all know it by now. Anti-telework is just collaborating with right-wing business interests."

-Chloe from Scranton Team Humans Newsletter

wdio.com/front-page/top-storie

WDIO.com · Gov. Walz announce change to state telework policyMinnesota Governor Tim Walz announced an update to the state's telework policy for state workers.
#Covid19#RTO#LiberalsAreDogshit
Public
cremevax👩🏻‍💻🏳️‍🌈​🇨🇦🇺🇦

Hello, it’s the (delayed this week -- sorry!) weekly #washingtonstate #kingcounty (that is, #seattle and environs) #COVID #COVID19 #wastewater toots.

A quick reminder that this King County respiratory disease data comes from Washington State, not the federal government.

Starting with the West Point (WSPT) sewage treatment plant: last week, the Sars-CoV2 7-day running average crept up a bit, though it is still at the low end of the scale, historically speaking. Last data is from 3/18.

WSPT is one of three King County(-ish) sewersheds in this dataset. You can find overviews, individual sewershed results, and a breakdown of variants for the state wastewater surveillance program, along with other metrics like case counts and hospitalizations for Covid-19 and other respiratory illnesses, at doh.wa.gov/data-and-statistica. If you go to the page and click "learn more" in the statewide view tab, you can find out lots of details about how these data are calculated and how to interpret them. The dashboard gets updated every Wednesday (generally). The WA Department of Health is here on the feditubes at @WADeptHealth.

Public
MrBlubber

Sieht so aus, als hilft die (mehrfache) mRNA #Covid19 Impfung nicht nur gegen Covid selbst sondern verstärkt auch das angeborene Immunsystem, was eine generelle verstärkte Immunabwehr auch gegen andere Erreger zur Folge haben könnte. Mega spannender Artikel. Wow!
nachrichten.idw-online.de/2025

Logo: Universität zu Köln
nachrichten.idw-online.demRNA-Coronaimpfung trainiert das „Langzeitgedächtnis“ des Immunsystems
Public
Augie Ray

Robert F. Kennedy Jr promised during his confirmation hearing to prioritize Long #Covid19 research. Guess what? The Trump administration is shuttering HHS’ #LongCovid office. Guess we've solved that problem. The 5 to 10% of Americans who suffer from LC (and the millions who'll succumb to it in the years ahead) are on their own.

politico.com/news/2025/03/24/t

ExploreLive feeds
About